These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36688679)

  • 1. Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways.
    Chen Y; Shen X; Ma T; Yu X; Kwok LY; Li Y; Sun Z; Li D; Zhang H
    mSystems; 2023 Feb; 8(1):e0130022. PubMed ID: 36688679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.
    Palacios T; Vitetta L; Coulson S; Madigan CD; Lam YY; Manuel R; Briskey D; Hendy C; Kim JN; Ishoey T; Soto-Giron MJ; Schott EM; Toledo G; Caterson ID
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32660025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes.
    Huang Y; Lou X; Jiang C; Ji X; Tao X; Sun J; Bao Z
    Front Endocrinol (Lausanne); 2022; 13():1044030. PubMed ID: 36465607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome.
    Liu A; Ma T; Xu N; Jin H; Zhao F; Kwok LY; Zhang H; Zhang S; Sun Z
    Microbiol Spectr; 2021 Oct; 9(2):e0085921. PubMed ID: 34612663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacterium lactis Probio-M8 improves bone metabolism in patients with postmenopausal osteoporosis, possibly by modulating the gut microbiota.
    Zhao F; Guo Z; Kwok LY; Zhao Z; Wang K; Li Y; Sun Z; Zhao J; Zhang H
    Eur J Nutr; 2023 Mar; 62(2):965-976. PubMed ID: 36334119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes.
    Sun B; Ma T; Li Y; Yang N; Li B; Zhou X; Guo S; Zhang S; Kwok LY; Sun Z; Zhang H
    mSystems; 2022 Apr; 7(2):e0010022. PubMed ID: 35343796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
    Caesar R
    Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
    Wu H; Esteve E; Tremaroli V; Khan MT; Caesar R; Mannerås-Holm L; Ståhlman M; Olsson LM; Serino M; Planas-Fèlix M; Xifra G; Mercader JM; Torrents D; Burcelin R; Ricart W; Perkins R; Fernàndez-Real JM; Bäckhed F
    Nat Med; 2017 Jul; 23(7):850-858. PubMed ID: 28530702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
    de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
    Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
    McMurdie PJ; Stoeva MK; Justice N; Nemchek M; Sieber CMK; Tyagi S; Gines J; Skennerton CT; Souza M; Kolterman O; Eid J
    BMC Microbiol; 2022 Jan; 22(1):19. PubMed ID: 34996347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics synergized with conventional regimen in managing Parkinson's disease.
    Sun H; Zhao F; Liu Y; Ma T; Jin H; Quan K; Leng B; Zhao J; Yuan X; Li Z; Li F; Kwok LY; Zhang S; Sun Z; Zhang J; Zhang H
    NPJ Parkinsons Dis; 2022 May; 8(1):62. PubMed ID: 35610236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.
    Tonucci LB; Olbrich Dos Santos KM; Licursi de Oliveira L; Rocha Ribeiro SM; Duarte Martino HS
    Clin Nutr; 2017 Feb; 36(1):85-92. PubMed ID: 26732026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The double-edged sword of probiotic supplementation on gut microbiota structure in
    Nabavi-Rad A; Sadeghi A; Asadzadeh Aghdaei H; Yadegar A; Smith SM; Zali MR
    Gut Microbes; 2022; 14(1):2108655. PubMed ID: 35951774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Intestinal Short-Chain Fatty Acid Metabolism Profile After Probiotics and GLP-1 Treatment for Type 2 Diabetes Mellitus.
    Min Q; Wang Y; Jin T; Zhu L; Wu X; Li Y; Wang Y; Xu N
    Front Endocrinol (Lausanne); 2022; 13():892127. PubMed ID: 35846273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin: old friend, new ways of action-implication of the gut microbiome?
    Rodriguez J; Hiel S; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.
    Zhang W; Xu JH; Yu T; Chen QK
    Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline gut microbiome as a predictive biomarker of response to probiotic adjuvant treatment in gout management.
    Zhao F; Tie N; Kwok LY; Ma T; Wang J; Man D; Yuan X; Li H; Pang L; Shi H; Ren S; Yu Z; Shen X; Li H; Zhang H
    Pharmacol Res; 2024 Nov; 209():107445. PubMed ID: 39396767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.